Community News
-
Development halts in first-generation gene therapies
MONTREAL, February 25, 2025 – On February 20, Pfizer announced that it was stopping development of its hemophilia B gene therapy, Beqvez. It cited “soft...
-
Now accepting applications for the James Kreppner Scholarship and Bursary Program
The competition for the James Kreppner Memorial Scholarship and Bursary Program is now open. DEADLINE TO APPLY: APRIL 30, 2025 CLICK HERE for all the details.
-
Your FEEDBACK matters to us!
The CHS is currently developing the next CHS Strategic Plan. We would appreciate your insights into how we can further our mission and enhance our...
-
Best wishes from the CHS!
Please CLICK HERE to read a special message from CHS President, Emil Wijnker, and Chief Executive Officer, Sarah Ford.
-
CHS survey of people with hemophilia A and their caregivers
In June and July 2024, the Canadian Hemophilia Society conducted an online survey regarding the lived experience of people with hemophilia A and their caregivers....